Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Searching for superstool: maximizing the therapeutic potential of FMT

Nature Reviews Gastroenterology & Hepatology volume 15, pages 387–388 (2018)Cite this article

Subjects

Faecal microbiota transplantation (FMT), a highly effective treatment for Clostridium difficile infection, is now being explored for complex diseases, but innovative trial design and collaborative approaches are essential for unlocking its therapeutic potential. If ‘superstool’ capable of treating a complex disease exists, then FMT trials should aim to find and use it.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Model of donor stool heterogeneity in treating complex diseases.

References

  1. Kassam, Z. et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am. J. Gastroenterol. 108, 500–508 (2013).

    Article  PubMed  Google Scholar 

  2. Allegretti, J. et al. The current landscape and lessons from fecal microbiota transplantation for inflammatory bowel disease: past, present, and future. Inflamm. Bowel Dis. 23, 1710–1717 (2017).

    Article  Google Scholar 

  3. Ott, S. J. et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152, 799–811.e7 (2017).

    Article  PubMed  Google Scholar 

  4. Turnbaugh, P. J. et al. The human microbiome project. Nature 449, 804–810 (2007).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Narula, N. et al. Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm. Bowel Dis. 23, 1702–1709 (2017).

    Article  PubMed  Google Scholar 

  6. Moayyedi, P. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102–109.e6 (2015).

    Article  PubMed  Google Scholar 

  7. Olesen, S. W., Gurry, T. & Alm, E. J. Designing fecal microbiota transplant trials that account for differences in donor stool efficacy. Stat. Methods Med. Res. https://doi.org/10.1177/0962280216688502 (2017).

    Article  PubMed  Google Scholar 

  8. Berry, S. M., Connor, J. T. & Lewis, R. J. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 313, 1619–1620 (2015).

    Article  PubMed  Google Scholar 

  9. Woodcock, J. & LaVange, L. M. Master protocols to study multiple therapies, multiple diseases, or both. N. Engl. J. Med. 377, 62–70 (2017).

    Article  PubMed  CAS  Google Scholar 

  10. Crum-Cianflone, N. F., Sullivan, E. & Ballon-Landa, G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J. Clin. Microbiol. 53, 1986–1989 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA

    Scott W. Olesen & Eric J. Alm

  2. Boston Children’s Hospital, Division of Gastroenterology and Nutrition, Inflammatory Bowel Disease Center, Boston, MA, USA

    McKenzie M. Leier & Stacy A. Kahn

  3. Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA

    Eric J. Alm

  4. The Broad Institute of MIT and Harvard, Cambridge, MA, USA

    Eric J. Alm

  5. Harvard Medical School, Boston, MA, USA

    Stacy A. Kahn

Authors
  1. Scott W. Olesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. McKenzie M. Leier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric J. Alm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stacy A. Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stacy A. Kahn.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olesen, S.W., Leier, M.M., Alm, E.J. et al. Searching for superstool: maximizing the therapeutic potential of FMT. Nat Rev Gastroenterol Hepatol 15, 387–388 (2018). https://doi.org/10.1038/s41575-018-0019-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-018-0019-4

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing